The forum will feature 20-minute presentations (including Q&A) from a curated selection of exciting start-up companies, all carefully selected through our screening processes. You will also see updated presentations from past presenting companies.
Mind Pharma, a Yale IP–backed biotech, develops next-gen psychedelic treatments for psychiatric and CNS disorders. Focus: depression, migraine, and cluster headaches. Its short-acting model improves scalability, offering less frequent dosing than J&J’s Esketamine. Proof of concept studies completed in 48 participants and more than 100 patients underway at Yale.
Optina is an AI-guided clinical decision support solution that enables early-stage detection, diagnosis and monitoring of multiple degenerative diseases. Optina enables clinicians to efficiently diagnose and monitor at-risk patients, conduct pre- and post- comparative analysis on prognosis and the effect of treatment, and predict how patients will respond to therapy.
BleedIO builds secure, scalable Bluetooth Low Energy (BLE) mesh networks that provide real-time tracking, monitoring, and environmental sensing—without relying on Wi-Fi, GPS, or the cloud. Unlike traditional systems, our technology operates entirely at the edge using a decentralized mesh infrastructure. That means no single point of failure, no cloud latency, and no expensive infrastructure upgrades.